natgillin/translations-raw huggingface dataset:
The syringes fit onto the bottle and have a kg-bodyweight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg bodyweight). 
Brizga se prilega na stekleničko in ima merilno skalo z oznakami telesne mase v kilogramih, ki ustrezajo vzdrževalnemu odmerku (to je 0,1 mg meloksikama na kilogram telesne mase).
Excipients: Ethanol, anhydrous 
Pomožne snovi: Etanol, brezvodni
Loxicom 1.5 mg/ml oral suspension or Loxicom 0.5 mg/ml oral suspension may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg bodyweight, 24 hours after administration of the injection. 
Zdravljenje lahko nadaljujemo s peroralno suspenzijo Loxicom 1,5 mg/ml ali s peroralno suspenzijo Loxicom 0,5 mg/ml, ki jih damo v odmerku po 0,1 mg meloksikama na kilogram telesne mase 24 ur po dajanju suspenzije za injiciranje.
Loxicom 20 mg/ml solution for injection for cattle, pigs and horses. 
Loxicom 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje
Polyethylene terephthalate bottle containing 10, 32, 100, 2 x 100 or 200 ml with two polyethylene/polypropylene measuring syringes. 
Polietilen-tereftalat plastenka po 10 ml, 32 ml, 100 ml, 2 x 100 ml ali 200 ml s priloženima dvema polietilensko/polipropilenskima merilnima brizgama.
5 ml, 15 ml and 30 ml 
5 ml, 15 ml in 30 ml
For the relief of post-operative pain following dehorning in calves. 
Za lajšanje pooperativne bolečine po odstranitvi rogov teletom.
STATEMENT OF THE ACTIVE SUBSTANCES 
Seznam pomožnih snovi
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory veterinary medicinal products or with anticoagulant agents. 
Ne uporabite sočasno z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili za uporabo v veterinarski medicini ali antikoagulantnimi sredstvi.
EXP {month/year} Shelf life after first opening the immediate packaging: 28 days 
EXP {mesec/leto} Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni
Single administration of 0.2 mg meloxicam/kg bodyweight (i.e. 0.04 ml/kg) when administration of meloxicam is to be continued as an oral follow-up therapy 
Enkratno dajanje 0,2 mg meloksikama/kg telesne mase (to je 0,04 ml/kg), kjer se bo dajanje meloksikama nadaljevalo v obliki peroralnega nadaljevalnega zdravljenja.
Treatment should be discontinued after 10 days if no clinical improvement is apparent. 
Če se klinično stanje ne izboljša, je treba zdravljenje po 10 dneh prekiniti.
Post-operative pain and inflammation following surgical procedures: In case additional pain relief is required, multimodal pain therapy should be considered. 
V primeru, da je potrebno dodatno lajšanje bolečine, je treba upoštevati tudi multimodalno zdravljenje bolečine.
Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery. 
Lajšanje pooperativne bolečine in vnetja po ortopedskih operacijah ter kirurških posegih na mehkih tkivih.
Ethanol, anhydrous 
Etanol, brezvodni
Each syringe is graduated in bodyweight, the 1 ml syringe is graduated from 0.5 kg to 15 kg and the 5 ml syringe for 2.5 kg to 75 kg. 
Brizgi imata merilno skalo z oznakami telesne mase v kilogramih in sicer 1 ml brizga za telesno maso od 0,5 kg do 15 kg, 5 ml pa za telesno maso od 2,5 kg do 75 kg.
Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight (i.e. 1.33 ml/10 kg bodyweight) on the first day. 
Začetni odmerek prvi dan zdravljenja je 0,2 mg meloksikama na kilogram telesne mase (to je 1,33 ml/10 kg telesne mase).
Therapeutic classification 
Terapevtske indikacije
EXP: Once opened use within 6 months. 
EXP: Odprto zdravilo uporabite v 6 mesecih.
Shelf-life of opened bottle: 6 months. 
Rok uporabnosti odprte plastenke: 6 mesecev.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS,IF ANY 
POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEPORABLJENEGA ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO
Meloxicam 1 mg / chewable tablet Meloxicam 2.5 mg / chewable tablet 
Meloksikam 1 mg / žvečljiva tableta Meloksikam 2,5 mg / žvečljiva tableta
Dosage: 
Odmerki:
Overdose (symptoms, emergency procedures, antidotes): In the case of overdose symptomatic treatment should be initiated. 
Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi): Pri prevelikem odmerjanju uvedite simptomatsko zdravljenje.
In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported. 
V zelo redkih primerih so poročali o hemoragični driski, hematemezi, razjedah prebavil in zvišani ravni jetrnih encimov.
Loxicom 5 mg/ml solution for injection for dogs and cats meloxicam2. 
Loxicom 5 mg/ml raztopina za injiciranje za pse in mačke meloksikam2.
The use of a meloxicam containing oral suspension for dogs may be considered for an even more precise dosing. 
Za še natančnejše odmerjanje presodite o uporabi peroralne suspenzije za pse, ki vsebuje meloksikam.
Active substance: Meloxicam 
Učinkovina: Meloksikam
In very rare cases (less than 1 animal in 10,000 animals treated, including isolated reports) gastrointestinal ulceration and elevated liver enzymes have been reported. 
Zelo redko (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri) so poročali o gastrointestinalnih ulceracijah in zvišani ravni jetrnih encimov.
Do not use after the expiry date which is stated on the carton and the bottle after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na škatli in steklenici po EXP.
Benzyl alcohol 10 mg 
Pomožna snov: Benzilalkohol 10 mg
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.04 ml/kg body weight) before surgery, for example at the time of induction of anaesthesia. 
Enkratno podkožno dajanje 0,2 mg meloksikama/kg telesne mase (to je 0,04 ml/kg telesne mase) pred operacijo, na primer ob indukciji anestezije.
Gastrointestinal ulceration and elevated liver enzymes were reported in very rare cases. 
Zelo redko so poročali o gastrointestinalnih ulceracijah in zvišani ravni jetrnih encimov.
Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the blister after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na zunanji ovojnini in viali po EXP.
6.1 List of Excipients 
6.1 Seznam pomožnih snovi
Cardboard box with either 1 or 12 colourless glass injection vial(s) each containing 30 ml, 50 ml or 100 ml. 
Kartonska škatla z 1 ali 12 brezbarvnimi steklenimi injekcijskimi vialami po 30 ml, 50 ml ali 100 ml. Kartonska škatla z 1, 6 ali 12 brezbarvnimi steklenimi injekcijskimi vialami po 250 ml.
The veterinary medicinal product is presented in 15 ml and 30 ml polyethylene terephthalate screw bottles with HDPE/LDPE child resistant caps. 
Zdravilo za uporabo v veterinarski medicini je pakirano v polietilen-tereftalat plastenke po 15 ml in 30 ml, z HDPE/LDPE za otroke varnim zapiralom.
Carton box 5 ml, 15 ml and 30 ml bottle 
Kartonska škatla: 5 ml, 15 ml and 30 ml steklenička
In very rare cases (less than 1 animal in 10,000 animals treated, including isolated reports) loss of appetite, lethargy, abdominal pain and colitis have been reported. 
Zelo redko (pri mmanj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri) so poročali o izgubi apetita, letargiji, bolečini v trebuhu in kolitisu.
Each syringe is graduated in bodyweight, the 1 ml syringe is graduated from 0.25 kg to 5.0 kg and the 5 ml syringe for 1 kg to 25 kg. 
Brizgi imata merilno skalo z oznakami telesne mase v kilogramih in sicer 1 ml brizga za telesno maso od 0,25 kg do 5 kg, 5 ml pa za telesno maso od 1 kg do 25 kg.
PACKAGE LEAFLET: Loxicom 50 mg/g oral paste for horses 
NAVODILO ZA UPORABO Loxicom 50 mg/g peroralna pasta za konje
Do not use in pregnant or lactating animals. 
Ne uporabite pri brejih in živalih v obdobju laktacije.
Route and method of administration 
Pot in način uporabe
Loxicom 1 mg chewable tablets for dogs Loxicom 2.5 mg chewable tablets for dogs meloxicam2. 
Loxicom 1 mg žvečljive tablete za pse Loxicom 2,5 mg žvečljive tablete za pse meloksikam2.
The veterinary medicinal product is presented in 5 ml, 15 ml and 30 ml polyethylene terephthalate screw bottles with HDPE/LDPE child resistant caps. 
Zdravilo za uporabo v veterinarski medicini je pakirano v polietilen-tereftalat plastenke po 5 ml, 15 ml in 30 ml, z HDPE/LDPE za otroke varnim zapiralom.
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN” Keep out of sight and reach of children. 
BESEDILO “ZDRAVILO SHRANJUJTE NEDOSEGLJIVO OTROKOM” Zdravilo shranjujte nedosegljivo otrokom.
Treatment is to be continued once daily by oral administration (at 24 hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg bodyweight (i.e. 0.667 ml/10 kg bodyweight). 
Zdravljenje nadaljujemo enkrat dnevno (v 24 urnih presledkih) s peroralnim, vzdrževalnim odmerkom po 0,1 mg meloksikama na kilogram telesne mase (to je 0,667 ml/10 kg telesne mase).
The 1 ml measuring polyethylene/polypropylene syringe has a kg-body weight scale for cats (0.5 to 10 kg). 
1 ml merilna polietilen/polipropilen brizga ima merilno skalo z oznakami telesne mase v kilogramih in sicer od 0,5 kg do 10 kg.
The active substance in Loxicom is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010. 
C. NAVEDBA NAJVIŠJIH DOVOLJENIH KOLIČIN OSTANKOV ZDRAVILA (MRL) Učinkovina v zdravilu Loxicom 50 mg/g peroralna pasta za konje je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.37/2010: Farmakološko aktivna snov
Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight (i.e. 4 ml/10 kg bodyweight) on the first day. 
Začetni odmerek prvi dan zdravljenja je 0,2 mg meloksikama na kilogram telesne mase (to je 4 ml/10 kg telesne mase).
Loxicom 20 mg/ml solution for injection for cattle, pigs and horses meloxicam 
Loxicom 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje meloksikam
Loxicom 5 mg/ml solution for injection for dogs and cats. 
Loxicom 5 mg/ml raztopina za injiciranje za pse in mačke
The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously. 
Poleg tega je treba v obdobju brez zdravljenja upoštevati farmakokinetične lastnosti zdravil, ki smo jih dajali predhodno.
MANUFACTURER'S BATCH NUMBER BN: 
PROIZVAJALČEVA ŠTEVILKA SERIJE Lot:
Once broached, use by … 
Načeto zdravilo uporabite do…
Each syringe has an integrated adapter with a “kg/body weight” graduation, in divisions of paste per 50 kg bodyweight. 
Vsaka brizga ima odmerni obroč in merilno skalo z oznakami telesne mase v kilogramih, razdelek pa predstavlja količino paste za 50 kg telesne mase.
Treatment is to be continued once daily by oral administration (at 24 hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg body weight. 
Zdravljenje nadaljujemo enkrat dnevno (v 24 urnih presledkih) s peroralnim, vzdrževalnim odmerkom po 0,05 mg meloksikama/kg telesne mase.
Apple flavour Sorbitol 
Ksantanski gumi Aroma jabolka Sorbitol
Manufacturer responsible for batch release: Norbrook Manufacturing Limited Rossmore Industrial Estate Monaghan Town 
Proizvajalec, odgovoren za sproščanje serij: Norbrook Manufacturing Limited Rossmore Industrial Estate Monaghan Town
Loxicom 5 mg/ml solution for injection for dogs and cats meloxicam 
Loxicom 5 mg/ml raztopina za injiciranje za pse in mačke meloksikam
People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product. 
Osebe z znano preobčutljivostjo za NSAR naj se izogibajo stiku z zdravilom za uporabo v veterinarski medicini.
Dogs: intravenous or subcutaneous use. 
Psi: intravensko ali subkutano dajanje Mačke: subkutano dajanje
Cardboard box with 1, 6 or 12 colourless glass injection vial(s) each containing 250 ml. 
Kartonska škatla z 1 ali 12 brezbarvnimi steklenimi injekcijskimi vialami po 30 ml, 50 ml ali 100 ml. Kartonska škatla z 1, 6 ali 12 brezbarvnimi steklenimi injekcijskimi vialami po 250 ml. Ni nujno, da so v prometu vsa navedena pakiranja.
METHOD AND ROUTE OF ADMINISTRATION 
Način in pot odmerjanja
Isolated cases of adverse reactions typically associated with NSAIDs were observed in clinical trials (slight urticaria, diarrhoea). 
V kliničnih preskušanjih so zasledili posamezne primere neželenih učinkov, ki so značilni za nesteroidna protivnetna zdravila (blaga utrikarija, driska).
More than 98% of meloxicam is bound to plasma proteins. 
Več kot 98 % meloksikama se veže na beljakovine v plazmi.
Loxicom 1 mg chewable tablets for dogs Loxicom 2.5 mg chewable tablets for dogs 
Loxicom 1 mg žvečljive tablete za pse Loxicom 2,5 mg žvečljive tablete za pse
EXP {month/year} Shelf life of broached vial: 28 days. 
Rok uporabnosti odprte viale: 28 dni.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. 
Pri dehidriranih, hipovolemičnih ali hipotenzivnih živalih se izogibamo dajanju zdravila zaradi možne povečane toksičnosti za ledvice.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents. 
Zdravila ne smete dajati hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulansi.
Approximately 98% of meloxicam is bound to plasma proteins. 
Porazdelitev Približno 98% meloksikama se veže na beljakovine v plazmi.
In case of overdose symptomatic treatment should be initiated. 
Pri prevelikem odmerjanju je treba uvesti simptomatsko zdravljenje.
Pharmacologically active substance 
NAVEDBA ZDRAVILNE UČINKOVINE
Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of renal toxicity. 
Pri dehidriranih, hipovolemičnih ali hipotenzivnih živalih se izogibajte dajanju zdravila zaradi možne nevarnosti toksičnih učinkov na ledvice.
Loxicom 2.5 mg chewable tablets for dogs: EU/2/08/090/023 - 1 x 10 tablets EU/2/08/090/024 - 2 x 10 tablets EU/2/08/090/025 - 10 x 10 tablets EU/2/08/090/026 - 50 x 10 tablets 
Loxicom 2,5 mg žvečljive tablete za pse EU/2/08/090/023 - 1 x 10 tabletes EU/2/08/090/024 - 2 x 10 tabletes EU/2/08/090/025 - 10 x 10 tabletes EU/2/08/090/026 - 50 x 10 tabletes
Shelf life after first broaching the glass vial: 28 days. 
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni.
Treatment is to be continued once daily by oral administration (at 24 hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg bodyweight (i.e. 2 ml/10 kg bodyweight). 
Zdravljenje nadaljujemo enkrat dnevno (v 24 urnih presledkih) s peroralnim, vzdrževalnim odmerkom po 0,1 mg meloksikama na kilogram telesne mase (to je 2 ml/10 kg telesne mase).
BT35 6PU 
Co Down, BT35 6PU Združeno Kraljestvo
Loxicom 1 mg chewable tablets for dogs: EU/2/08/090/019 - 1 x 10 tabletes EU/2/08/090/020 - 2 x 10 tabletes EU/2/08/090/021 - 10 x 10 tabletes EU/2/08/090/022 - 50 x 10 tabletes 
Loxicom 1 mg žvečljive tablete za pse EU/2/08/090/019 - 1 x 10 tabletes EU/2/08/090/020 - 2 x 10 tabletes EU/2/08/090/021 - 10 x 10 tabletes EU/2/08/090/022 - 50 x 10 tabletes
The suspension can be given using either of the two measuring syringes provided in the package. 
Suspenzijo je treba odmeriti z merilno brizgo, ki je sestavni del pakiranja.
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight. 
Zdravljenje nadaljujte enkrat dnevno (v 24 urnih presledkih) s peroralnim, vzdrževalnim odmerkom po 0,1 mg meloksikama na kilogram telesne mase.
Loxicom 0.5 mg/ml oral suspension for dogs meloxicam 
Loxicom 0,5 mg/ml, peroralna suspenzija za pse meloksikam
5 ml, 15 ml and 30 ml bottle label 
5 ml, 15 ml in 30 ml plastenka
10 and 20 ml bottle 
10 ml in 20 ml steklenička
Alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders in cats. 
Umirjanje vnetja in lajšanje bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih pri mačkah.
30 ml and 50 ml bottle 
30 ml in 50 ml steklena viala
Pre-treatment with other anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. 
Predzdravljenje z drugimi zdravili s protivnetnim delovanjem lahko povzroči dodatne neželene učinke ali jih okrepi, zato teh zdravil za uporabo v veterinarski medicini ne smemo dajati najmanj 24 ur pred začetkom zdravljenja.
Overdose (symptoms, emergency procedures, antidotes): In case of overdose symptomatic treatment should be initiated. 
4.10 Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) V primeru vnosa prevelikega odmerka je treba uvesti simptomatsko zdravljenje.
In case of overdose, symptomatic treatment should be initiated. 
Pri prevelikem odmerjanju uvedemo simptomatsko zdravljenje.
In very rare cases (less than 1 animal in 10,000 animals treated, including isolated reports), haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported. 
Zelo redko (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri) so poročali o hemoragični driski, hematemezi, razjedah prebavil in zvišani ravni jetrnih encimov.
Marketing authorisation holder: Norbrook Laboratories (Ireland) Limited Rossmore Industrial Estate Monaghan 
Imetnik dovoljenja za promet z zdravilom: Norbrook Laboratories (Ireland) Limited Rossmore Industrial Estate Monaghan
Initial treatment is a single oral dose of 0.1 mg meloxicam/kg bodyweight on the first day. 
Prvi dan zdravljenja je začetni enkratni peroralni odmerek 0,1 mg meloksikama/kg telesne mase.
Carton box 15 and 30 ml bottle 
Kartonska škatla: 15 ml in 30 ml plastenka
10 and 32 ml bottle 
10 ml in 32 ml plastenka
Loxicom 0.5 mg/ml oral suspension for dogs meloxicam2. 
Loxicom 0,5 mg/ml peroralna suspenzija za pse meloksikam2.
Excipients: Sodium benzoate 
Pomožna snov: Natrijev benzoat
Do not use after the expiry date stated on the carton and the bottle. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na škatli in brizgi.
Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight on the first day. 
Prvi dan zdravljenja je začetni enkratni peroralni odmerek 0,2 mg meloksikama/kg telesne mase.
Dogs: Single administration of 0.2 mg meloxicam/kg bodyweight (i.e. 0.4 ml/10 kg). 
Enkratno dajanje 0,2 mg meloksikama na kilogram telesne mase (to je 0,4 ml/10 kg).
Alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders. 
Umirjanje vnetja in lajšanje bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih.
Typical adverse reactions of non-steroidal anti-inflammatory drugs NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. 
Občasno so poročali o značilnih neželenih učinkih nesteroidnih protivnetnih zdravil, kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev), apatija in odpoved ledvic.
Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. 
Ne uporabite pri živalih z obolenji prebavil, kot so zdraženost prebavil in krvavitev, oslabljeno delovanje jeter, srca ali ledvic ter hemoragične motnje.
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs. 
Umirjanje vnetja in lajšanje bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih pri psih.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. 
Predzdravljenje z zdravili s protivnetnim delovanjem lahko povzroči dodatne neželene učinke ali jih okrepi, zato se teh zdravil ne sme dajati najmanj 24 ur pred začetkom zdravljenja.
BN {number} 
Lot {številka}
In very rare cases (less than 1 animal in 10,000 animals treated, including isolated reports), haemorrhagic diarrhoea, haematemesis and gastrointestinal ulceration have been reported. 
Zelo redko (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri) so poročali o hemoragični driski, hematemezi in razjedi prebavil.
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders. 
Za umirjanje vnetja in lajšanje bolečine pri akutnih in kroničnih mišično-skeletnih obolenjih.
Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. 
Ne uporabite pri konjih z obolenji prebavil, kot so zdraženost prebavil in krvavitve, oslabljeno delovanje jeter, srca ali ledvic ter hemoragične motnje.
Marketing authorisation holder Norbrook Laboratories (Ireland) Limited Rossmore Industrial Estate Monaghan 
Imetnik dovoljenja za promet z zdravilom Norbrook Laboratories (Ireland) Limited Rossmore Industrial Estate Monaghan
Cattle and Pigs: 
Uporaba v obdobju brejosti in laktacije: Govedo in prašiči:
Do not use in cats suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. 
Ne uporabite pri mačkah z obolenji prebavil, kot so zdraženost prebavil in krvavitve, oslabljeno delovanje jeter, srca ali ledvic ter hemoragične motnje.
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. 
Občasno so poročali o značilnih neželenih učinkih NSAID, kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev), apatija in odpoved ledvic.
STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS 
NAVEDBA UČINKOVIN(E) IN DRUGE(IH) SESTAVIN Vsak ml vsebuje
People with known hypersensitivity to Non-Steroidal AntiInflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product. 
Osebe z znano preobčutljivostjo na nesteroidna protivnetna zdravila (NSAR) naj se izogibajo stiku z zdravilom za uporabo v veterinarski medicini.
Equidae 
INDIKACIJAE
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. 
V primeru nenamernega samoinjiciranja se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
hours before commencement of treatment. 
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA
Target tissues 
España Laboratorios Karizoo
Typical adverse drug reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. 
Občasno so poročali o značilnih neželenih učinkih nesteroidnih protivnetnih zdravil (NSAR), kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev),letargija in odpoved ledvic.
Should irritation occur and persist, seek medical advice. 
Če draženje ne preneha, se posvetujte z zdravnikom.
Loxicom 1.5 mg/ml oral suspension for dogs. 
Loxicom 1,5 mg/ml peroralna suspenzija za pse meloksikam2.
Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. 
Ne uporabite pri psih z obolenji prebavil, kot so zdraženost prebavil in krvavitev, oslabljeno delovanje jeter, srca ali ledvic ter hemoragične motnje.
Shelf-life after first opening the immediate packaging: 28 days 
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported. 
Občasno so poročali o značilnih neželenih učinkih NSAR, kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev), letargija in odpoved ledvic.
Pale yellow solution 
Bleda rumena raztopina.
QUALITATIVE AND QUANTITATIVE COMPOSITION 
KAKOVOSTNA IN KOLIČINSKA SESTAVA En ml vsebuje:
Pack size 
Pretisni omot